Stealth BioTherapeutics (Stealth BioTherapeutics) COGS-to-Revenue : 0.00 (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics COGS-to-Revenue?

Stealth BioTherapeutics's Cost of Goods Sold for the three months ended in Mar. 2022 was $0.00 Mil. Its Revenue for the three months ended in Mar. 2022 was $0.00 Mil.

Stealth BioTherapeutics's COGS to Revenue for the three months ended in Mar. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Stealth BioTherapeutics's Gross Margin % for the three months ended in Mar. 2022 was N/A%.

Stealth BioTherapeutics COGS-to-Revenue Historical Data

The historical data trend for Stealth BioTherapeutics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics COGS-to-Revenue Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

COGS-to-Revenue

Get a 7-Day Free Trial

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Stealth BioTherapeutics COGS-to-Revenue Calculation

Stealth BioTherapeutics's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Stealth BioTherapeutics's COGS to Revenue for the quarter that ended in Mar. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Stealth BioTherapeutics (NAS:MITO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Stealth BioTherapeutics's Gross Margin % for the three months ended in Mar. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Stealth BioTherapeutics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.